Health Canada drug identification number

DIN 02468425 — SHINGRIX 50 MCG

SHINGRIX is a suspension of Varicella-Zoster Virus Glycoprotein E Antigen marketed by GLAXOSMITHKLINE INC. The full Varicella-Zoster Virus Glycoprotein E Antigen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02468425
Brand name
SHINGRIX
Strength
50 MCG
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Manufacturer
GLAXOSMITHKLINE INC
Health Canada status
MARKETED
Drug class
Non-live recombinant subunit vaccine (adjuvanted active immunizing agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.